PMHS
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin,… Read more
Market Cap & Net Worth: PMHS (PMHS)
PMHS (PINK:PMHS) has a market capitalization of $10.94 Million ($10.94 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #31664 globally and #10419 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PMHS's stock price $0.39 by its total outstanding shares 28053090 (28.05 Million).
PMHS Market Cap History: 2025 to 2025
PMHS's market capitalization history from 2025 to 2025. Data shows growth from $10.94 Million to $10.94 Million (0.00% CAGR).
PMHS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PMHS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PMHS by Market Capitalization
Companies near PMHS in the global market cap rankings as of March 18, 2026.
Key companies related to PMHS by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
PMHS Historical Marketcap From 2025 to 2025
Between 2025 and today, PMHS's market cap moved from $10.94 Million to $ 10.94 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $10.94 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PMHS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.94 Million USD |
| MoneyControl | $10.94 Million USD |
| MarketWatch | $10.94 Million USD |
| marketcap.company | $10.94 Million USD |
| Reuters | $10.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.